Japan · Series B startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Mitsubishi UFJ Capital
SMBC Venture Capital
Mizuho Capital
Keio Innovation InitiativeSource recorded
From Neusignal Therapeutics's own website: 4 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Neusignal Therapeutics's investors include Mitsubishi UFJ Capital, SMBC Venture Capital, Mizuho Capital, Nissay Capital and FFG Venture Business Partners, and 1 more on record.
Neusignal Therapeutics has raised $40M across 2 rounds since 2025.
Neusignal Therapeutics's most recent round was a Series B of $33M in Jun 2026.
Its most recent round, $33M in Jun 2026, is also its largest on record.
Neusignal Therapeutics's first round on record, in Jan 2025, was backed by Mitsubishi UFJ Capital, SMBC Venture Capital and Mizuho Capital and 2 others.
Neusignal Therapeutics's latest named round is a Series B, in Jun 2026.
Neusignal Therapeutics is based in Japan.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Japan · 
